MRNA Stock – Rwanda’s Paul Kagame Says Working on Africa mRNA Vaccine Plant
Rwandan President Paul Kagame said his country is in talks to establish the first mRNA vaccine plant in Africa as the continent battles the coronavirus pandemic.
“Rwanda is working with partners to bring the first mRNA manufacturing facility to Africa,” Kagame said at a virtual event this week organized by the Independent Panel for Pandemic Preparedness and Response. He didn’t give further details.
Africa has few manufacturing facilities of any kind and most that do exist can only package and distribute the inoculations — so called fill-finish facilities — rather than make the ingredients needed for the shots.
mRNA vaccines differ from traditional inoculations in that they use edited messenger RNA, or ribonucleic acid, to protect the body against pathogens. PFE US Equity”/>Pfizer Inc., together with (BNTX) US Equity”/>BioNTech SE, has developed an mRNA vaccine to fight Covid-19, as has MRNA US Equity”/>Moderna Inc. Their shots have so far proved more effective than those produced by other companies using more traditional methods.
“I had the opportunity to initiate contacts with different manufacturers of vaccines specifically focusing on the messenger RNA technique used by Moderna and Pfizer,” Kagame said last month. “We have been involved in discussions and I have briefed a few colleagues on our continent but we want to take it forward by discussing it with others.”
To date, only about 20 million Africans out of a continent of 1.3 billion have been vaccinated against Covid-19.